The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.
LATEST NEWS
Keeping an "Eye on Innovation" Through News & Analysis
Oyster Point Pharma Goes Public
Oyster Point Pharma is now officially listed on the Nasdaq Global Market under “OYST.” Initial share pricing was $16; to date the stock’s high has ...
Digging deep in the retina pipeline
While Novartis’ recently approved Beovu soaked up a lot of the buzz in the retina space at the American Academy of Ophthalmology, reports of early ...
OIS’ First International Venue
Why Israel? Did you know Tel Aviv has the highest number of startups per capita in the world? (It also boasts the most GDP investment ...
OIS Index on Positive Upswing
The OIS Index of ophthalmic stocks gained 5.2% in October, posting its first month of positive performance since June. The index lagged the biotech sector ...
Private Financing Trends: Ophthalmology Ranks Tenth
SAN FRANCISCO, Calif. — Almost $25 billion in venture funds have been raised in just the United States alone over the past 2.5 years to ...
Opthea’s Star Brightens for Stakeholders
It’s been a good year for Opthea Ltd., a biotechnology company based in Melbourne, Australia. It’s listed on the Australian Securities Exchange (ASX), trading as ...
LATEST PODCASTS
Candid Conversations With Ophthalmology's Innovators & Business Leaders
TESTIMONIALS
Why People Attend OIS
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.